The Claim
Ketoconazole and CYP27B1 siRNA inhibit UV-induced MMP-1 expression in human keratinocytes by blocking the synthesis of 1α,25-dihydroxyvitamin D3.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Ketoconazole and CYP27B1 siRNA reduce the production of MMP-1 protein in human skin cells exposed to UV light by preventing the formation of 1α,25-dihydroxyvitamin D3.
See the scientific wording
Ketoconazole and CYP27B1 siRNA inhibit UV-induced MMP-1 expression in human keratinocytes by blocking 1α,25-dihydroxyvitamin D3 synthesis.
When skin is exposed to UV light, it stops making cholesterol and starts making a form of vitamin D instead. This vitamin D binds to a receptor in skin cells, which turns on a gene that breaks down collagen. Blocking this vitamin D production prevents the collagen breakdown.
What the research says
1 studyWhen skin is exposed to UV light, it makes more of a vitamin D form that triggers a collagen-breaking enzyme. But when scientists blocked that vitamin D production using specific drugs or genetic tools, the enzyme didn’t increase — meaning stopping vitamin D production stops the damage.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.